Power Wheelchair Group 2 denied as duplicate or overlapping therapy by UnitedHealthcare?

UnitedHealthcare's Commercial policy states that mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POVs), canes, and walkers are a covered health care service when medically necessary. The policy applies the Medicare DME MAC LCD for Power Mobility Devices (L33789) criteria, which require that the beneficiary has a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home, where the mobility limitation prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completion within a reasonable time frame. The beneficiary's mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. For a Group 2 Single Power Option PWC (K0835–K0840), all basic coverage criteria (a)–(e) must be met, plus the beneficiary requires a drive control interface other than a hand or chin-operated standard proportional joystick (e.g., head control, sip and puff, switch control), OR meets coverage criteria for a power tilt or power recline seating system being used on the wheelchair, AND has had a specialty evaluation performed by a licensed/certified medical professional (PT, OT, or practitioner) with specific training and experience in rehabilitation wheelchair evaluations documenting medical necessity. The wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) who specializes in wheelchairs and has direct, in-person involvement in the wheelchair selection. Section 6407 of the ACA requires a face-to-face encounter, documented by a physician (or NP, PA, or CNS), occurring within the 6 months before the order is written for the DME. Weight-class criteria apply: a Heavy Duty PWC is covered for beneficiaries weighing 285–450 pounds, Very Heavy Duty for 428–600 pounds, and Extra Heavy Duty for 570 pounds or more. Payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document in-home MRADL impairment in detail** — Provide specific examples of how the member cannot independently/safely complete toileting, feeding, dressing, grooming, or bathing in the home, mapping directly to the LCD MRADL definition: a mobility limitation that prevents accomplishment of an MRADL, places the beneficiary at heightened risk of morbidity/mortality, or prevents completion within a reasonable time frame. - **Demonstrate failure of lesser alternatives** — Include PT/OT trial documentation showing that the beneficiary lacks sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day due to weakness, fatigue, pain, ROM limits, or absent extremities, satisfying LCD basic criterion C. - **Submit a compliant specialty evaluation and ATP attestation** — Provide the LCMP/PT/OT evaluation with the no-financial-relationship attestation per the requirement of a signed and dated attestation by the supplier or LCMP that the LCMP has no financial relationship with the supplier , plus documentation that the wheelchair is provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) who specializes in wheelchairs and has direct, in-person involvement in the wheelchair selection. - **Justify the Group 2 power option upgrade** — For K0835–K0840, document either a non-standard drive control need (head control, sip-and-puff, switch) OR concurrent need for a power tilt/recline system per the LCD requirement that the beneficiary requires a drive control interface other than a hand or chin-operated standard proportional joystick, or meets coverage criteria for a power tilt or power recline seating system being used on the wheelchair. - **Provide a timely 7-element order and face-to-face note** — Submit the in-window F2F note and order; per the LCD policy article, the 7-element order must be received by the supplier within 45 days after completion of the face-to-face examination , and per CMS, the encounter must occur within the 6 months before the order is written. - **Verify accurate weight-class coding** — Confirm the member's weight aligns with the prescribed class boundaries set by the LCD: Heavy Duty 285–450 lb, Very Heavy Duty 428–600 lb, and Extra Heavy Duty 570 lb or more , and amend the HCPCS code if a misclassification triggered the denial. - **Cite clinical/professional standards** — Reference RESNA's position papers on the application of power wheelchairs and seat-elevation/tilt systems, and AOTA/APTA wheelchair assessment guidelines, to support the medical necessity narrative that mirrors LCD L33789 — the framework UnitedHealthcare explicitly adopts via its Mobility Devices policy and the DME MAC LCD for Power Mobility Devices (L33789).

## UnitedHealthcare Medicare Advantage — Power Wheelchair Group 2 (K0835–K0843) Denied as Duplicate Therapy

A "duplicate therapy" denial on a Group 2 PWC is almost always a one-chair-at-a-time application of LCD L33789 — UHC's MA plan is asserting the member already has a covered mobility device on file (manual wheelchair, scooter/POV, prior PWC base, or a rental still inside its 13-month cap-rental window) and refusing to pay for a second simultaneously. UHC Medicare Advantage delegates PWC coverage to the DME MAC LCD framework, and CMS only pays for one wheelchair at a time — backup chairs are explicitly "not reasonable and necessary." This is the mechanic driving the denial, not a clinical dispute about MRADL limitation.

The appeal must therefore reframe the second device as replacement, upgrade, or medically distinct configuration, not a duplicate. Four winning fact patterns:

1. Reasonable Useful Lifetime (RUL) expiration — 42 CFR §414.210(f) sets PWC RUL at 5 years from initial date of service. If the prior chair is past RUL, it is a replacement, not a duplicate, and UHC must process it as new equipment. Pull the CMN/SWO date from the prior supplier. 2. Irreparable damage / loss / theft — documented by police report, fire report, or supplier's repair estimate showing cost exceeds 60% of replacement. LCD L33789 permits replacement before RUL on this basis. 3. Change in medical condition — progression (ALS, MS exacerbation, post-CVA contracture, new ventilator dependence) that the prior chair cannot accommodate. This is the lever for stepping a K0835 user up to K0841–K0843 Multiple Power Option: the new neurological condition or vent-mount requirement is the LCD trigger. 4. Distinct site-of-use — a Group 2 PWC for the home is not duplicative of a manual chair used as a transport backup; cite CMS Medicare Benefit Policy Manual Ch. 15 §110 "in the home" definition.

UHC Medicare Advantage prior-auth on PMDs flows through Optum as the delegated UM vendor. Under 42 CFR §422.566 the plan owes a written organization determination with the specific LCD criterion failed; "duplicate therapy" without naming which prior HCPCS is duplicative is a non-compliant denial. Demand the redetermination under 42 CFR §422.582 within 60 days, and escalate to the Part C Independent Review Entity (Maximus Federal) if upheld. For ERISA-governed commercial UHC plans (non-MA), invoke 29 CFR §2560.503-1(g) disclosure rights and Pinto v. Aetna (10th Cir. 2014) to force production of the internal medical-necessity rubric Optum used.

Tactical tip: Attach the PT/OT specialty evaluation required by LCD L33789(e) for any K0835–K0843 with the prior chair's serial number, delivery date, and a one-line statement from the supplier confirming the prior chair has been picked up, junked, or is past RUL. That single sentence collapses the "duplicate" theory because there is no second active chair on the claim history.